Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ototoxicity × Drug Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 137 Breast Neoplasms 89 Colorectal Neoplasms 67 Neoplasms 56 Lung Neoplasms 50 Stomach Neoplasms 47 Neoplasm Metastasis 45 Pancreatic Neoplasms 43 Rectal Neoplasms 39 Ovarian Neoplasms 39 Esophageal Squamous Cell Carcinoma 36 Esophageal Neoplasms 31 Squamous Cell Carcinoma of Head and Neck 28 Head and Neck Neoplasms 28 Leukemia, Myeloid, Acute 26 Triple Negative Breast Neoplasms 21 Recurrence 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Nasopharyngeal Carcinoma 20 Colonic Neoplasms 20 Small Cell Lung Carcinoma 19 Lymphoma 17 Glioblastoma 17 Fallopian Tube Neoplasms 17 Uterine Cervical Neoplasms 16 Prostatic Neoplasms 16 Lymphoma, Non-Hodgkin 16 Sarcoma 15 Leukemia 14 Carcinoma, Squamous Cell 14

Interventions

Cisplatin 4 sodium thiosulfate 3 Methotrexate 2 Chemotherapy, Adjuvant 2 tempol 1 ebselen 1 Vorinostat 1 Vincristine 1 Thioctic Acid 1 Surveys and Questionnaires 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiosurgery 1 Pantoprazole 1 Mental Status and Dementia Tests 1 Magnetic Resonance Spectroscopy 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Hyaluronic Acid 1 Hearing Tests 1 Drug Therapy 1 Dexamethasone 1 Cyclophosphamide 1 Chemoradiotherapy 1 Carboplatin 1 Audiometry 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡